Invus Public Equities, L.P.
- SEC CIK
- 0001340097
No open-market purchases or sales filed in the past year.
Current role at each company
- SRRK Scholar Rock Holding Corp10% Owneras of Dec 12, 2024
- CBIO Crescent Biopharma, Inc.10% Owneras of Aug 9, 2024
- LXRX Lexicon Pharmaceuticals, Inc.Director, 10% Owneras of May 14, 2024
- OMGA Omega Therapeutics, Inc.10% Owneras of Aug 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Invus Public Equities, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRRK Scholar Rock Holding Corp
10% Owner8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 (view filing)4:39 PM ET | Dec 10 | 2 days | Debbane Raymond and 4 others10% Owner | SSale | −1.60M | $41.65 | −$66.6M | −14.7%9.25M after | |
| Nov 27, 2024 (view filing)4:31 PM ET | Nov 25 | 2 days | Debbane Raymond and 4 others10% Owner | SSale | −409.4K | $38.49 | −$15.8M | −3.6%10.9M after | 5 lots |
| Oct 16, 2023 (view filing)5:46 PM ET | Oct 12 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +2.20M | $6.86 | +$15.1M | +24.3%11.3M after | 2 lots |
| May 2, 2023 (view filing)9:00 PM ET | Apr 28 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +31.6K | $6.43 | +$202.8K | +0.3%9.06M after | |
| Jan 11, 2023 (view filing)8:30 PM ET | Jan 9 | 2 days | Artal Group S.A. and 7 others10% Owner | SSale | −1.09K | $9.48 | −$10.4K | 0.0%9.03M after | |
| Jan 9, 2023 (view filing)5:22 PM ET | Jan 5 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +48.8K | $9.33 | +$455.1K | +0.5%9.03M after | |
| Oct 27, 2022 (view filing)4:36 PM ET | Oct 25 | 2 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +130.3K | $8.04 | +$1.05M | +1.5%8.98M after | |
| Oct 7, 2022 (view filing)4:30 PM ET | Oct 3-4 | 4 daysLate | Artal Group S.A. and 7 others10% Owner | PPurchase | +100.0K | $7.60 | +$759.5K | +1.1%8.85M after | 2 lots |
CBIO Crescent Biopharma, Inc.
10% Owner8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2024 (view filing)4:30 PM ET | Aug 7-8 | 2 days | Debbane Raymond and 4 others10% Owner | SSale | −322.4K | $0.1899 | −$61.2K | −4.9%6.32M after | 2 lots |
| Aug 7, 2024 (view filing)4:30 PM ET | Aug 5-6 | 2 days | Debbane Raymond and 4 others10% Owner | SSale | −220.3K | $0.187 | −$41.2K | −3.2%6.64M after | 2 lots |
| Aug 5, 2024 (view filing)4:53 PM ET | Aug 1-2 | 4 days | Debbane Raymond and 4 others10% Owner | SSale | −349.8K | $0.2033 | −$71.1K | −4.9%6.86M after | 2 lots |
| Jul 30, 2024 (view filing)5:16 PM ET | Jul 26-30 | 4 days | Debbane Raymond and 4 others10% Owner | SSale | −1.38M | $0.2286 | −$315.3K | −16.1%7.21M after | 3 lots |
| Feb 28, 2023 (view filing)5:33 PM ET | Feb 24 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +100.0K | $1.70 | +$170.0K | +1.2%8.59M after | |
| Feb 23, 2023 (view filing)6:23 PM ET | Feb 21-23 | 2 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +400.0K | $1.78 | +$712.3K | +4.9%8.49M after | 3 lots |
| Feb 17, 2023 (view filing)5:29 PM ET | Feb 15-17 | 2 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +1.52M | $2.00 | +$3.03M | +23.1%8.09M after | 3 lots |
| Feb 13, 2023 (view filing)5:45 PM ET | Feb 9 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +11.5K | $3.24 | +$37.1K | +0.2%6.57M after |
LXRX Lexicon Pharmaceuticals, Inc.
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 (view filing)4:46 PM ET | Jun 5 | Same day | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +27.8M | $2.60 | +$72.2M | +54.6%78.6M after | |
| Aug 9, 2022 (view filing)4:46 PM ET | Aug 5 | 4 days | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +2.43M | $2.50 | +$6.07M | +5.0%50.9M after | |
| Aug 1, 2022 (view filing)4:15 PM ET | Aug 1 | Same day | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +16.2M | $2.50 | +$40.4M | +50.1%48.4M after |
OMGA Omega Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 (view filing)5:16 PM ET | Jul 30-Aug 3 | 4 days | Artal Group S.A. and 8 others10% Owner | PPurchase | +950.0K | $16.93 | +$16.1M | +71.8%2.27M after | 2 lots |